Eltrombopag is a prescription medication used to prevent bleeding episodes in patients with chronic immune (idiopathic) thrombocytopenia (ITP) or chronic hepatitis C virus (HCV). Eltrombopag belongs to a group of drugs called thrombopoietin receptor agonist, which work by causing the cells of the bone marrow to produce more platelets (cells that are needed for blood to clot).

Eltrombopag is a prescription medicine used to treat low blood platelet counts to lower the risk for bleeding in adults with:

chronic immune (idiopathic) thrombocytopenia (ITP), when other medicines to treat your ITP or surgery to remove the spleen have not worked well enough.

chronic hepatitis C virus (HCV) infection before and during treatment with interferon.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Starting dose:

50 mg taken by mouth once daily

If you are of East Asian ancestry: 25 mg taken by mouth once daily

Mild, moderate, or severe liver impairment: 25 mg taken by mouth once daily

If you are of Easy Asian ancestry who also has mild, moderate, or severe liver impairment: 12.5 mg once daily

Maintenance:

Your doctor with adjust your dose to achieve & maintain a certain platelet level in the blood

Maximum daily dose: 75 mg

Discontinue if:

no improvement is seen after 4 weeks at the maximum dose, or...

if liver tests are abnormal, or...

if platelet levels are too high as determined by your doctor.